Loading clinical trials...

COMPLETEDPhase 2NCT00674297

Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients

The purpose of this study is to determine whether a drug named Fluvastatin is beneficial and safe in reducing the risk of cardiovascular disease and blood clots in patients with antiphospholipid antib...

Lead sponsor: Hospital for Special Surgery, New York•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Rheumatology Patient Registry and Biorepository

NCT04402086 · Rheumatic Diseases, Adult Onset Still Disease, and more

RECRUITING

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

NCT07372170 · Antiphospholipid Syndrome (APS), Venous Thrombosis (Disorder), and more

RECRUITING

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

NCT00616317 · Antiphospholipid Syndrome

RECRUITINGPhase 1/2

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

NCT06828042 · Systemic Lupus Erthematosus, Systemic Sclerosis (SSc), and more

RECRUITINGPhase 1

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

NCT06978647 · Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 1, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment41

Start dateMay 2008

Last updatedMay 1, 2018

Condition

Antiphospholipid Syndrome

Locations shown

Hospital for Special Surgery

New York, New York

Division of Rheumatology, University of Texas Medical Branch

Galveston, Texas

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2018Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Rheumatology Patient Registry and Biorepository

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Trial snapshot

Condition

Locations shown

For caregivers